Cargando…

Buprenorphine

In the crystal structure of a semi-synthetic opioid drug buprenorphine, C(29)H(41)NO(4) {systematic name: (2S)-2-[(5R,6R,7R,14S)-9α-cyclopropylmethyl-3-hydroxy-6-methoxy-4,5-epoxy-6,14-ethanomorphinan-7-yl]-3,3-dimethylbutan-2-ol}, the cyclopropylmethyl group is disordered over two sites w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazurek, Jaroslaw, Hoffmann, Marcel, Fernandez Casares, Anna, Cox, Phillip D., Minardi, Mathew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union of Crystallography 2014
Materias:	Organic Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051008/ https://www.ncbi.nlm.nih.gov/pubmed/24940223 http://dx.doi.org/10.1107/S1600536814009672

Ejemplares similares

Two orthorhombic polymorphs of hydromorphone
por: Mazurek, Jaroslaw, et al.
Publicado: (2016)

The crystal structures of two novel polymorphs of bis(oxonium) ethane-1,2-disulfonate
por: Mazurek, Jaroslaw, et al.
Publicado: (2019)

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2012)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

1,3-Dibenzylimidazolidine-2-thione
por: Mietlarek-Kropidłowska, Anna, et al.
Publicado: (2012)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

N-(4-Methylpiperazin-4-ium-1-yl)dithiocarbamate sesquihydrate
por: Mietlarek-Kropidłowska, Anna, et al.
Publicado: (2012)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

BUPRENORPHINE WITHDRAWAL SYNDROME
por: Tripathi, B.M., et al.
Publicado: (1995)

Pharmacokinetic–Pharmacodynamic Modeling of the Effectiveness and Safety of Buprenorphine and Fentanyl in Rats
por: Yassen, Ashraf, et al.
Publicado: (2007)

Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
por: Vierke, Christopher, et al.
Publicado: (2020)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

Pharmacokinetics of transdermal buprenorphine patch in the elderly
por: Al-Tawil, Nabil, et al.
Publicado: (2012)

3,3′-Dibenzoyl-1,1′-dibenzyl-1,1′-(ethane-1,2-diyl)dithiourea
por: Okuniewski, Andrzej, et al.
Publicado: (2012)

N-Benzoyl-N′-phenylurea
por: Okuniewski, Andrzej, et al.
Publicado: (2010)

4,4′-(1,2,4,5-Tetrazine-3,6-diyl)dibenzonitrile
por: Dutkiewicz, Grzegorz, et al.
Publicado: (2009)

1,3-Di-n-butylthiourea
por: Okuniewski, Andrzej, et al.
Publicado: (2011)

(Z)-N-[2-(Dimethylammonio)ethyl]thioacetamide chloride
por: Dutkiewicz, Grzegorz, et al.
Publicado: (2007)

N,N′-Diphenylthiourea acetone monosolvate
por: Okuniewski, Andrzej, et al.
Publicado: (2010)

CASE REPORT OF SUBSTANCE DEPENDENCE WITH BUPRENORPHINE AND MEPHENTERMINE
por: Mendhekar, D.N., et al.
Publicado: (1999)

catena-Poly[[[bis(thiourea-κS)cadmium]-di-μ-thiocyanato-κ(2) N:S;κ(2) S:N] dihydrate]
por: Mietlarek-Kropidłowska, Anna, et al.
Publicado: (2012)

Benefits of using intrathecal buprenorphine
por: Rabiee, Seyed Mozaffar, et al.
Publicado: (2014)

BUPRENORPHINE ABUSE IN INDIA : AN UPDATE
por: Sharma, Yogesh, et al.
Publicado: (1999)

Buprenorphine: Far Beyond the “Ceiling”
por: Infantino, Rosmara, et al.
Publicado: (2021)

5,5-Dimethyl-2-methylseleno-1,3,2-dioxaphosphorinan-2-one
por: Cholewinski, Grzegorz, et al.
Publicado: (2010)

O-Pivaloyl diphenylselenophosphinate
por: Cholewinski, Grzegorz, et al.
Publicado: (2009)

O-4-Chlorobenzoyl diphenylselenophosphinate
por: Cholewinski, Grzegorz, et al.
Publicado: (2009)

1,1,2,2-Tetrakis(diisopropylamino)diphosphane
por: Grubba, Rafał, et al.
Publicado: (2009)

Methyl 3-[(1,1-dioxo-1λ(6),2-benzothiazol-3-yl)amino]-5-nitrothiophene-2-carboxylate
por: Rode, Haridas B., et al.
Publicado: (2012)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
por: Simojoki, Kaarlo, et al.
Publicado: (2008)

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
por: Janganati, Venumadhav, et al.
Publicado: (2023)

4,10-Diallyloxy-1,2,3,6b,7,8,9,12b-octahydroperylene
por: Smith, Terrill D., et al.
Publicado: (2009)

4-[(tert-Butyldimethylsilyl)oxy]-6-methoxy-7-methyl-5-(oxiran-2-ylmethyl)-2-benzofuran-3(1H)-one
por: Malachowska-Ugarte, Magdalena, et al.
Publicado: (2011)

Tetra-n-butylammonium iodido(pyrrolidine-1-carbodithioato-κ(2) S,S′)(tris-tert-butoxysilanethiolato-κS)cadmate(II)
por: Kropidłowska, Anna, et al.
Publicado: (2008)

(2S,4S)-3-Acryloyl-6-oxo-2-phenylperhydropyrimidine-4-carboxylic acid
por: Kundu, Sandip K., et al.
Publicado: (2009)

Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences
por: Neale, Joanne, et al.
Publicado: (2019)

Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
por: Komatsu, Ryu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_toisr6jkv59tk6lcafespal7dr